全文获取类型
收费全文 | 828篇 |
免费 | 42篇 |
国内免费 | 18篇 |
专业分类
耳鼻咽喉 | 8篇 |
儿科学 | 13篇 |
妇产科学 | 38篇 |
基础医学 | 75篇 |
口腔科学 | 38篇 |
临床医学 | 76篇 |
内科学 | 151篇 |
皮肤病学 | 5篇 |
神经病学 | 46篇 |
特种医学 | 30篇 |
外科学 | 201篇 |
综合类 | 50篇 |
一般理论 | 1篇 |
预防医学 | 35篇 |
眼科学 | 11篇 |
药学 | 37篇 |
肿瘤学 | 73篇 |
出版年
2023年 | 9篇 |
2022年 | 23篇 |
2021年 | 25篇 |
2020年 | 12篇 |
2019年 | 20篇 |
2018年 | 31篇 |
2017年 | 30篇 |
2016年 | 17篇 |
2015年 | 21篇 |
2014年 | 33篇 |
2013年 | 38篇 |
2012年 | 44篇 |
2011年 | 80篇 |
2010年 | 39篇 |
2009年 | 47篇 |
2008年 | 62篇 |
2007年 | 63篇 |
2006年 | 45篇 |
2005年 | 47篇 |
2004年 | 49篇 |
2003年 | 46篇 |
2002年 | 37篇 |
2001年 | 7篇 |
2000年 | 10篇 |
1999年 | 8篇 |
1998年 | 6篇 |
1997年 | 8篇 |
1996年 | 4篇 |
1995年 | 2篇 |
1994年 | 3篇 |
1993年 | 3篇 |
1992年 | 3篇 |
1991年 | 3篇 |
1990年 | 2篇 |
1988年 | 1篇 |
1987年 | 1篇 |
1986年 | 1篇 |
1984年 | 2篇 |
1983年 | 2篇 |
1982年 | 1篇 |
1981年 | 1篇 |
1980年 | 1篇 |
1979年 | 1篇 |
排序方式: 共有888条查询结果,搜索用时 78 毫秒
71.
72.
73.
James D. Johnston Saija A. Kontulainen Bassam A. Masri David R. Wilson 《Skeletal radiology》2010,39(9):867-876
Objective
The objective was to identify subchondral bone density differences between normal and osteoarthritic (OA) proximal tibiae using computed tomography osteoabsorptiometry (CT-OAM) and computed tomography topographic mapping of subchondral density (CT-TOMASD). 相似文献74.
75.
76.
77.
A phase Ib,open‐label,single arm study to assess the safety,pharmacokinetics, and impact on humoral sensitization of SANGUINATE infusion in patients with end‐stage renal disease
下载免费PDF全文
![点击此处可从《Clinical transplantation》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Bassam G. Abu Jawdeh Ervin Steve Woodle Abbie D. Leino Paul Brailey Simon Tremblay Tonya Dorst Mouhamad H. Abdallah Amit Govil Daniel Byczkowski Hemant Misra Abraham Abuchowski Rita R. Alloway 《Clinical transplantation》2018,32(1)
The endeavor to study desensitization in kidney transplantation has not been matched by an effort to investigate strategies to prevent sensitization. In this study (NCT02437422), we investigated the safety, impact on sensitization, and pharmacokinetics of SANGUINATE (SG), a hemoglobin‐based oxygen carrier, as a potential alternative to packed red blood cells (PRBC) in transplant candidates with end‐stage renal disease (ESRD). Ten ESRD subjects meeting inclusion/exclusion (I/E) criteria were planned to receive three weekly infusions of SG (320 mg/kg). The study was stopped after five subjects were enrolled, and their data were analyzed after completing a follow‐up period of 90 days. Two subjects had elevated troponin I levels in setting of SG infusion, one of which was interpreted as a non‐ST elevation myocardial infarction. All other adverse events were transient. SG pharmacokinetic analysis showed mean (SD) Cmax, Tmax, AUC, and half‐life of 4.39 (0.69) mg/mL, 2.42 (0.91) hours, 171.86 (52.35) mg h/mL, and 40.60 (11.96) hours, respectively. None of the subjects developed new anti‐HLA antibodies following SG infusion and throughout the study period. In conclusion, SG is a potential alternative to PRBCs in ESRD patients considered for kidney transplantation as it was not associated with humoral sensitization. Larger studies in highly sensitized patients are required to further evaluate for potential safety signals. 相似文献
78.
Longitudinal assessment of hepatic fibrosis in responders to direct‐acting antivirals for recurrent hepatitis C after liver transplantation using noninvasive methods
下载免费PDF全文
![点击此处可从《Clinical transplantation》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Heba Omar Mohamed Said Rasha Eletreby Mai Mehrez Mohamed Bassam Zeinab Abdellatif Adel Hosny Sherif Megawer Mona El Amir Ayman Yosry 《Clinical transplantation》2018,32(8)
Successful eradication of recurrent hepatitis C virus (HCV) infection following liver transplantation (HCV) improves graft survival. This study aimed at evaluation of hepatic fibrosis changes among long‐term responders to DAA therapy for recurrent HCV after liver transplantation using noninvasive methods. Patients with significant hepatic fibrosis (≥F2) who achieved SVR12 after treatment with DAAs for recurrent HCV were included (n = 52). Hepatic fibrosis status was assessed, noninvasively, by calculation of fibrosis‐4 score (FIB‐4) and Aspartate Aminotransferase Platelet Ratio Index (APRI) and by measurement of graft stiffness using FibroScan at baseline and 12 and 18 months post‐treatment. Acoustic radiation force imaging (ARFI) was done for all patients 12 and 18 months post‐treatment. Patients were classified into two groups based on baseline liver stiffness measurement (LSM) by FibroScan; significant fibrosis (F2; n = 28) and advanced fibrosis groups (≥F3). Over 18‐month follow‐up period, there was serial improvement of FIB‐4, APRI, and LSM by FibroScan in both groups. Higher baseline LSM and delayed initiation of antiviral therapy were significant predictors of lack of fibrosis regression (P‐value 0.01 and 0.04, respectively). Fibroindices and LSM improved over time in liver transplant recipients who responded to DAAs. Baseline LSM can predict post‐treatment fibrosis regression. 相似文献
79.
肝癌是较常见且恶性程度很高的恶性肿瘤之一,早期诊断主要依赖各种影像学方法和血清甲胎蛋白的检测,但是由于小肝癌的超声表现缺乏特异性,即使应用彩色多普勒超声诊断仍存在较多困难。近年来,由于新型声学造影剂及其 相似文献
80.